🎉 Hepatitis C is Now Curable: Modern Direct-Acting Antiviral (DAA) medications cure Hepatitis C in over 95% of patients — with just 8–12 weeks of oral tablets, no injections, minimal side effects.
What is Hepatitis C?
Hepatitis C (HCV) is a viral infection that primarily attacks the liver. India has approximately 6–12 million people living with chronic HCV. Unlike Hepatitis B, there is no vaccine — but unlike Hepatitis B, HCV can be completely cured with antiviral treatment.
How HCV Spreads
- Contaminated blood: Primary route — shared needles, unsafe injections in healthcare settings (before 1992 blood screening), transfusions
- Unsafe medical procedures: Non-sterile dental equipment, dialysis without proper precautions
- Tattooing and body piercing with unsterilised equipment
- Sexual transmission: Lower risk than HBV, but possible especially with multiple partners
- NOT spread through food, water, hugging, sharing utensils, coughing, or breastfeeding
Why HCV is Called the "Silent Killer"
75–85% of people with acute HCV develop chronic infection. Of these:
- Most have NO symptoms for 10–30 years
- 20–30% develop cirrhosis over 20 years
- 1–4% per year of cirrhotics develop liver cancer
- Most are diagnosed incidentally on routine blood tests
Diagnosis
- Anti-HCV antibody test: Screening test — positive means past or present exposure
- HCV RNA (PCR): Confirms active infection, quantifies viral load
- HCV Genotype: Identifies which of 6 genotypes (1–6) — determines treatment regimen and duration
- LFT, CBC: Assesses liver inflammation and function
- FibroScan: Stages fibrosis — critical for treatment planning and post-cure monitoring
Treatment: Direct-Acting Antivirals (DAAs)
The revolution in Hepatitis C treatment happened between 2013–2016. DAAs work by directly blocking HCV replication — they are highly specific, potent, and well-tolerated.
| Regimen | Genotype | Duration | Cure Rate |
|---|
| Sofosbuvir + Velpatasvir (Epclusa) | All genotypes (1–6) | 12 weeks | >95% |
| Glecaprevir + Pibrentasvir (Maviret) | All genotypes | 8–12 weeks | >97% |
| Sofosbuvir + Ledipasvir (Harvoni) | Genotype 1, 4, 5, 6 | 8–12 weeks | >95% |
| Sofosbuvir + Daclatasvir | All genotypes | 12–24 weeks | 90–95% |
What Does "Cured" Mean?
Cure is defined as Sustained Virological Response (SVR) — undetectable HCV RNA 12 weeks after completing treatment. SVR means the virus is gone permanently. Once achieved:
- Liver inflammation stops immediately
- Early fibrosis may partially reverse
- Cirrhosis risk drops dramatically
- Liver cancer risk falls by ~75%
- Patients with cirrhosis still need 6-monthly surveillance
Frequently Asked Questions
What is the cost of Hepatitis C treatment in Bangalore?
Generic DAA medications made in India are much more affordable than branded versions. Sofosbuvir-based regimens typically cost ₹15,000–45,000 for a complete course depending on genotype and duration. Many insurance policies now cover HCV treatment. Please contact us for current pricing.
Are there side effects of DAA therapy?
DAAs are remarkably well-tolerated compared to old interferon-based regimens. Common mild effects: headache, fatigue in the first week. Serious side effects are rare. Most patients complete treatment without any significant issues.
Can I get Hepatitis C again after being cured?
Yes — SVR means the virus is eliminated, but there is no protective immunity like with vaccines. Reinfection is possible if you are re-exposed. It is equally treatable if that happens.
My liver tests are normal — do I still need treatment?
Yes. Normal ALT does not mean no liver damage — fibrosis can progress silently with normal liver enzymes in 30% of HCV patients. All patients with active HCV infection (detectable HCV RNA) are recommended for treatment.